Literature DB >> 36149511

Computational insights into the differentiated binding affinities of Myc, Max, and Omomyc dimers to the E-boxes of DNA.

Yuxin Dai1, Jinyuan Zhang1, Yinchuan Wang1, Linlin Liu2,3, Jian Gao4.   

Abstract

Myc is a bHLHZip protein involved in growth control and cancer, which does not form a homodimer. Myc operates in a network with its heterodimerization partner Max, the latter of which can form homodimer and heterodimer. Omomyc, a polypeptide, can block Myc to treat cancers because it can both homodimerize as efficiently as Max and heterodimerize with both Myc and Max. However, the binding efficiencies to DNA for the mentioned two homodimers (Omomyc-Omomyc and Max-Max) and three heterodimers (Myc-Max, Omomyc-Myc, and Omomyc-Max) are still controversial. By molecular dynamics simulations and MM/GBSA free energy calculation, we ranked the binding affinities of five dimers to DNA and analyzed the contribution of single amino acids to the molecular recognition of dimers to DNA. Our simulation showed that the Omomyc-Omomyc dimer exhibited the highest binding energy to DNA, followed by the Omomyc-Myc, Max-Max, Omomyc-Max, and Myc-Max dimers. Moreover, five Arg residues (i.e., 7, 8, 15, 17, and 18 numbered by Omomyc) and five Lys residues (i.e., 6, 22, 40, 43, and 48 numbered by Omomyc) dominated the binding of various dimers to DNA while the residues Asp23 and Asp37 weakened the affinities via repulsive interaction. Our simulation would provide worthy information for further development of the structure-based design of novel Omomyc-like peptide inhibitors against Myc in the future.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  MM/GBSA; Max; Molecular dynamics simulation; Myc; Omomyc

Year:  2022        PMID: 36149511     DOI: 10.1007/s00894-022-05261-1

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   2.172


  16 in total

1.  X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors.

Authors:  Satish K Nair; Stephen K Burley
Journal:  Cell       Date:  2003-01-24       Impact factor: 41.582

2.  The Myc-ARF-Egr1 pathway: unleashing the apoptotic power of c-Myc.

Authors:  David N Boone; Stephen R Hann
Journal:  Cell Cycle       Date:  2011-07-01       Impact factor: 4.534

3.  OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumors.

Authors:  L A Jung; A Gebhardt; W Koelmel; C P Ade; S Walz; J Kuper; B von Eyss; S Letschert; C Redel; L d'Artista; A Biankin; L Zender; M Sauer; E Wolf; G Evan; C Kisker; M Eilers
Journal:  Oncogene       Date:  2016-10-17       Impact factor: 9.867

Review 4.  MYC and tumor metabolism: chicken and egg.

Authors:  Francesca R Dejure; Martin Eilers
Journal:  EMBO J       Date:  2017-11-10       Impact factor: 11.598

5.  Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.

Authors:  E M Blackwood; R N Eisenman
Journal:  Science       Date:  1991-03-08       Impact factor: 47.728

6.  c-Myc inhibits myoblast differentiation and promotes myoblast proliferation and muscle fibre hypertrophy by regulating the expression of its target genes, miRNAs and lincRNAs.

Authors:  Wen Luo; Jiahui Chen; Limin Li; Xueyi Ren; Tian Cheng; Shiyi Lu; Raman Akinyanju Lawal; Qinghua Nie; Xiquan Zhang; Olivier Hanotte
Journal:  Cell Death Differ       Date:  2018-05-21       Impact factor: 15.828

Review 7.  MYC modulators in cancer: a patent review.

Authors:  Xiao-Na Wang; Xiao-Xuan Su; Sui-Qi Cheng; Zhi-Yin Sun; Zhi-Shu Huang; Tian-Miao Ou
Journal:  Expert Opin Ther Pat       Date:  2019-05-08       Impact factor: 6.674

8.  Determination of binding constant of transcription factor myc-max/max-max and E-box DNA: the effect of inhibitors on the binding.

Authors:  Seyeon Park; Sunah Chung; Kyung-Mee Kim; Kyung-Chae Jung; Chihoon Park; Eun-Ryeong Hahm; Chul-Hak Yang
Journal:  Biochim Biophys Acta       Date:  2004-02-24

Review 9.  The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis.

Authors:  Patrick A Carroll; Brian W Freie; Haritha Mathsyaraja; Robert N Eisenman
Journal:  Front Med       Date:  2018-07-27       Impact factor: 4.592

10.  Impact of c-MYC expression on proliferation, differentiation, and risk of neoplastic transformation of human mesenchymal stromal cells.

Authors:  Svitlana Melnik; Nadine Werth; Stephane Boeuf; Eva-Maria Hahn; Tobias Gotterbarm; Martina Anton; Wiltrud Richter
Journal:  Stem Cell Res Ther       Date:  2019-03-05       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.